Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ginkgo Bioworks Hldgs Inc (DNA)

Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 619,158
  • Shares Outstanding, K 2,211,278
  • Annual Sales, $ 251,460 K
  • Annual Income, $ -892,870 K
  • 60-Month Beta 1.14
  • Price/Sales 2.67
  • Price/Cash Flow N/A
  • Price/Book 0.62
Trade DNA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.35
  • Most Recent Earnings $-0.08 on 05/09/24
  • Next Earnings Date 08/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 251.67% ( -43.44%)
  • Historical Volatility 122.89%
  • IV Percentile 98%
  • IV Rank 82.38%
  • IV High 295.11% on 07/18/24
  • IV Low 48.61% on 03/27/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 2,426
  • Volume Avg (30-Day) 3,609
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 241,459
  • Open Int (30-Day) 231,846

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.07
  • Low Estimate -0.08
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2642 +5.98%
on 06/27/24
0.4600 -39.13%
on 06/21/24
-0.1410 (-33.49%)
since 06/18/24
3-Month
0.2642 +5.98%
on 06/27/24
1.1300 -75.22%
on 04/29/24
-0.5849 (-67.63%)
since 04/19/24
52-Week
0.2642 +5.98%
on 06/27/24
2.5400 -88.98%
on 07/27/23
-2.2600 (-88.98%)
since 07/19/23

Most Recent Stories

More News
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?

A recovery plan is underway, but it isn't a slam dunk.

DNA : 0.2800 (-7.62%)
Why Ginkgo Bioworks Stock Is Sinking Today

There was double trouble for this beaten-down biotech stock.

DNA : 0.2800 (-7.62%)
ARKK : 46.63 (+0.13%)
ARKG : 25.38 (-0.67%)
Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These pharma and biotech players could become long-term winners.

SNY : 50.62 (+0.52%)
NVAX : 13.85 (-7.42%)
PFE : 29.97 (+0.88%)
DNA : 0.2800 (-7.62%)
Ginkgo Bioworks Stock: Bull vs. Bear

This innovative biotechnology company hopes to turn things around.

PFE : 29.97 (+0.88%)
DNA : 0.2800 (-7.62%)
Should You Buy the Dip on Ginkgo Bioworks Stock?

Its vision is ambitious, but can it actually be made to work?

DNA : 0.2800 (-7.62%)
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk

You don't need to buy her picks, but it's worth understanding them.

RHHBY : 39.2700 (-0.18%)
ARKK : 46.63 (+0.13%)
ARKG : 25.38 (-0.67%)
DNA : 0.2800 (-7.62%)
RXRX : 7.61 (-3.30%)
3 Things You Need to Know if You Buy Ginkgo Bioworks Today

It needs to work within the constraints imposed by these three issues.

DNA : 0.2800 (-7.62%)
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?

The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price.

DNA : 0.2800 (-7.62%)
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst

Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,

DNA : 0.2800 (-7.62%)
Is Ginkgo Bioworks Holdings Stock a Buy?

Can this struggling stock turn things around?

DNA : 0.2800 (-7.62%)

Business Summary

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 0.3230
2nd Resistance Point 0.3144
1st Resistance Point 0.2972
Last Price 0.2800
1st Support Level 0.2714
2nd Support Level 0.2628
3rd Support Level 0.2456

See More

52-Week High 2.5400
Fibonacci 61.8% 1.6706
Fibonacci 50% 1.4021
Fibonacci 38.2% 1.1336
Last Price 0.2800
52-Week Low 0.2642

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar